NEW YORK (GenomeWeb) – A steep decline in the broader biotechnology space dragged down shares of life science omics tools and molecular diagnostic firms in September. 

Compared to August, the GenomeWeb Index fell nearly 8 percent last month, following a similar nearly 8 percent drop month over month in August. Of the 31 companies comprising the index, just two, NanoString Technologies and Hologic, registered month-over-moth gains in September.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.